Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine
MT Voso, E Fabiani, A Piciocchi, C Matteucci… - Leukemia, 2011 - nature.com
MT Voso, E Fabiani, A Piciocchi, C Matteucci, L Brandimarte, C Finelli, E Pogliani…
Leukemia, 2011•nature.com3 Brown JR, Levine RL, Thompson C, Basile G, Gilliland DG, Freedman AS. Systematic
genomic screen for tyrosine kinase mutations in CLL. Leukemia 2008; 22: 1966–1969. 4
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and
down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic
leukemia. Proc
genomic screen for tyrosine kinase mutations in CLL. Leukemia 2008; 22: 1966–1969. 4
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and
down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic
leukemia. Proc
3 Brown JR, Levine RL, Thompson C, Basile G, Gilliland DG, Freedman AS. Systematic genomic screen for tyrosine kinase mutations in CLL. Leukemia 2008; 22: 1966–1969. 4 Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc
nature.com
